The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasm
Roberta S. Azevedo(The University of Texas MD Anderson Cancer Center), N. Pemmaraju, Adolfo de la Fuente, Matthew L. Ulrickson, Melissa L. Larson, Tülin Budak-Alpdoǧan, Suki Subbiah(Ochsner Health System), C DAVIS, Leonard C. Alsfeld(Ochsner Medical Center), Sumeet Bhatia, Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Laura Finn, Zohra Nooruddin
Cited by 0
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
|New England Journal of Medicine|2023|437
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|255